- European indices finished today’s session higher, with DAX0 up 1.14% led by autos and healthcare stocks. Deutsche Bank stock rose over 6% amid mood improvement in the banking sector.
-
Latest solvency figures of other major banks turned out to be better compared to Credit Suisse, to be acquired by UBS
-
Germany's IFO survey rose to 93.3 in March, the highest level in a year.
-
Some of the fears of a broader threat to the global financial system eased somehow after US lender First Citizens BancShares said it would purchase the loans and deposits of Silicon Valley Bank.
-
In addition, the US authorities are considering increasing deposit guarantees for regional banks so that they have time to improve their balance sheets
-
On the other hand, sentiment on Wall Street is mixed. The S&P 500 is up about 0.8%, S%P500 rose 0.45% while the Nasdaq 100 is down almost 0.20%.
-
With less chance of banking collapse and a repeat of 2007-2009 scenario, crude oil rebounds 4% today end reached level not seen since March 15
-
On the other hand, NATGAS tumbles nearly 5% due to low consumption and high temperatures in the US
-
US 10 Year Treasury yield jumped above 3.50%,however EURUSD is testing resistance at 1.0800
-
The cryptocurrency market pulled back quite sharply on news that Binance and its CEO were sued by the CFTC over trading and derivatives violations.
SILVER failed to stay above crucial resistance at $23.20. As long as price sits below the aforementioned level, downward impulse towards crucial support at $22.00 may be launched. Source: xStation5
Daily summary: Wall Street climbs higher as oil falls 📈 SpaceX surges 28%
Oil slides 2.5% to $88 as Middle East tensions ease 📉 Is the uptrend over?
Wall Street Rebounds as Oil Prices Fall 📈 Adobe Shares Drop 8% After Earnings
French luxury companies and banks gain as the inflation rises
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
